These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32651994)

  • 21. Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas.
    Qiu MJ; Chen YB; Bi NR; Yang SL; He XX; Xiong ZF
    Dis Markers; 2018; 2018():9191639. PubMed ID: 30416612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival comparison between primary hepatic neuroendocrine neoplasms and primary pancreatic neuroendocrine neoplasms and the analysis on prognosis-related factors.
    Li MX; Li QY; Xiao M; Wan DL; Chen XH; Zhou L; Xie HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):538-545. PubMed ID: 30981633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological features and prognostic validity of WHO grading classification of SI-NENs.
    Chen L; Zhou L; Zhang M; Shang L; Zhang P; Wang W; Fang C; Li J; Xu T; Tan H; Zhang P; Qiu M; Yu X; Jin K; Chen Y; Chen H; Lin R; Zhang Q; Shen L; Chen M; Li J; Li L; Chen J
    BMC Cancer; 2017 Aug; 17(1):521. PubMed ID: 28778195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic characteristics and survival outcomes in neuroendocrine carcinoma of the ovary.
    Zhu Y; Meng F; Fang H; Zhang Z; Wang L; Zheng W
    Int J Gynecol Cancer; 2020 Feb; 30(2):207-212. PubMed ID: 31796530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
    Mosquera C; Koutlas NJ; Fitzgerald TL
    Eur J Surg Oncol; 2016 Oct; 42(10):1471-7. PubMed ID: 27528467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
    Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
    Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical resection of high-grade nonfunctional pancreatic neuroendocrine carcinoma is associated with improved survival.
    Jiang J; Park J; Kim S; Daan A; Donahue T; Girgis MD
    J Surg Oncol; 2021 Dec; 124(8):1373-1380. PubMed ID: 34406651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of clinical information in patients with gastroenteropancreatic neuroendocrine tumor.
    Kudo A; Akashi T; Kumagai J; Ban D; Inokuchi M; Kojima K; Kawano T; Tanaka S; Arii S
    Hepatogastroenterology; 2012; 59(120):2450-3. PubMed ID: 22584507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases.
    Lee KC; Chuang SK; Philipone EM; Peters SM
    Head Neck Pathol; 2019 Sep; 13(3):378-385. PubMed ID: 30357539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
    Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
    Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of gender on survival outcomes in patients with small intestinal stromal tumors: a comprehensive analysis using the SEER database.
    Yang J; Guo P; Zhang Z; Lu C; Qiao Z
    Surg Endosc; 2024 Jul; 38(7):3905-3916. PubMed ID: 38831215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marital status, an independent predictor for survival of gastric neuroendocrine neoplasm patients: a SEER database analysis.
    Zhou YJ; Lu XF; Zheng KI; Wang QW; Chen JN; Zhang QW; Yan FR; Li XB
    BMC Endocr Disord; 2020 Jul; 20(1):111. PubMed ID: 32703291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres.
    Frizziero M; Wang X; Chakrabarty B; Childs A; Luong TV; Walter T; Khan MS; Morgan M; Christian A; Elshafie M; Shah T; Minicozzi A; Mansoor W; Meyer T; Lamarca A; Hubner RA; Valle JW; McNamara MG
    World J Gastroenterol; 2019 Oct; 25(39):5991-6005. PubMed ID: 31660035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Grade in Neuroendocrine Tumor Metastases Negatively Impacts Survival.
    Keck KJ; Choi A; Maxwell JE; Li G; O'Dorisio TM; Breheny P; Bellizzi AM; Howe JR
    Ann Surg Oncol; 2017 Aug; 24(8):2206-2212. PubMed ID: 28560597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study.
    Wu L; Fu J; Wan L; Pan J; Lai S; Zhong J; Chung DC; Wang L
    Oncotarget; 2017 Jan; 8(3):4935-4947. PubMed ID: 27903960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour grade and primary site predict patterns of recurrence and survival in patients with resected gastroenteropancreatic neuroendocrine tumors.
    Watanabe A; Yip L; Hamilton TD; Loree JM; Stuart HC
    Am J Surg; 2021 Jun; 221(6):1141-1149. PubMed ID: 33795127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical analysis of gastroenteropancreatic neuroendocrine tumor with liver metastasis, compared with primary hepatic neuroendocrine tumor.
    Shen YH; Chen S; Zhang WT; Ji Y; Yu L; Sun HC; Qiu SJ; Ren N; Zhou J
    J Cancer Res Ther; 2014 Dec; 10 Suppl():276-80. PubMed ID: 25693935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term Outcomes of Gastroenteropancreatic Neuroendocrine Tumors.
    Chi W; Warner RRP; Chan DL; Singh S; Segelov E; Strosberg J; Wisnivesky J; Kim MK
    Pancreas; 2018 Mar; 47(3):321-325. PubMed ID: 29401168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
    Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM
    Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.